Dengue virus News
Dengue is one of the major vector-borne diseases in India and needs to be controlled with the necessary precautions to control the spread of the disease.
Dengue virus has evolved to be more severe in India
Researchers reveals four broad categories of dengue virus
India still has no approved vaccines against dengue
The Dengue virus causes severe illness and fever.
This illness is spread to people by the bite of a mosquito carrying the pathogen.
The patient with dengue fever requires rest, attention, and a nourishing diet. As the mercury hits high during our battle with dengue, fruits can be our best friends.
The number of dengue patients is increasing rapidly in Bihar. Patients also died in some areas, while in some areas the beds in the hospital have become less according to the number of patients.
Amidst the increasing cases of dengue in Delhi-NCR, now the threat of black fungus is also looming. In Ghaziabad, a person was found suffering from black fungus after dengue. This is the second case of black fungus in NCR.
There are four distinct dengue virus types circulating in India: DENV-1, DENV-2, DENV-3 and DENV-4.
The Aedes Aegypti mosquito is the main vector that transmits the dengue virus.
Researchers report that mosquitoes carrying dengue virus (DENV) can be genetically engineered, giving an increased resistance to infection by the virus.
The vaccine will be targeted against all the four serotypes of dengue virus that cause fever, headache, muscle and joint pain, rash in humans.
Like Zika virus, Dengue is transmitted by the mosquito, Aedes aegypti. Dengue, called break bone fever, is notable for causing severe bone and muscle pain, headache and pain behind the eyes.
Union Health Minister JP Nadda said he has asked for steps to be taken to prevent entry and transmission in India of the virus.
Dengue virus infects 390 million people worldwide each year through the bite of mosquitoes of the Aedes genus.
Researchers have identified "broadly neutralizing" antibodies that protect against infection by multiple, distantly related alphaviruses, including Chikungunya virus, that cause fever and debilitating joint pain.
Scientists have also been able to detect antibodies against CRVP379 in human blood samples, demonstrating that the protein is able to elicit an immune response in humans.
NS1 is one of the seven proteins composing the dengue virus and more specifically its replication machinery.
A major increase in cases of dengue will likely occur throughout Southeast Asian countries early next year, researchers have warned.
An international consortium has rewritten the `cartography` of dengue virus.
The Odisha government on Wednesday said it was well prepared, and there was no panic-like situation yet, following the first dengue related death of the year in the state.
At present, there is no specific approved vaccine or therapy to prevent dengue fever. But now a Bengaluru-based lab has come up with a tablet to treat the dreaded vector-borne disease.
Loading...